Automatic surveillance system for patients with gastric premalignant lesions
Official title: Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions
Run by Renmin Hospital of Wuhan University · NCT06039917 · Data updated 2026-11-12
This study is testing whether an automatic monitoring system can help people with gastric premalignant lesions keep up with their check-ups better than manual reminders or no help at all.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1460 (estimated) |
| Sponsor | Renmin Hospital of Wuhan University Academic / other |
| Locations | 4 sites (Quanzhou, Fujian and 3 other locations) |
| Status | Recruiting |
| Started | September 10, 2023 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | November 4, 2024 |
| Trial ID | NCT06039917 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 years or older who are undergoing upper endoscopy and have gastric premalignant lesions.
✕Probably not a fit
Patients with high-grade intraepithelial neoplasia, esophageal or gastric cancer, or those deemed unsuitable for clinical trials will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of an automatic surveillance system designed to improve the monitoring of patients with gastric premalignant lesions. Participants will be divided into three groups: one receiving intelligent surveillance via an AI system, another receiving manual reminders, and a control group with no intervention. The goal is to compare the surveillance rates among these groups to determine the impact of the automatic system. This approach aims to enhance adherence to surveillance guidelines, which is crucial for early detection and management.
Why it matters
Potential benefit: If successful, this study could significantly improve the surveillance rates for patients with gastric premalignant lesions, leading to better patient outcomes.
How similar studies have gone: Previous studies have shown promise in using automatic surveillance systems for patient monitoring, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female aged 18 years or older who undergo upper endoscopy. Exclusion Criteria: * 1)No contact information or invalid contact information. * 2\) The surveillance interval cannot be determined according to the surveillance guidelines, including no upper gastrointestinal pathology, therapeutic endoscopy or with history of previous gastrectomy, esophagectomy, or ESD, no dysplasia degrees, no biopsy sites, non-epithelial lesions, duodenal lesions, ulcer and so on. * 3\) Needless for surveillance or others. * 4\) High-grade intraepithelial neoplasia or cancer of the esophagus or stomach. * 5\) Low-grade intraepithelial neoplasia of the esophagus and Barrett's esophagus. * 6\) High-risk diseases or other special conditions for which the patient is deemed unsuitable for clinical trials by the investigator.
Where it's running
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, China Recruiting -
Shanghai Pudong Hospital
Shanghai, Shanghai Municipality, China Recruiting -
Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus
Quanzhou, Fujian, China Not yet recruiting -
The Eighth Hospital of Wuhan
Wuhan, Hubei, China Not yet recruiting
Study contacts
- Principal investigator: Honggang Yu, PhD — Renmin Hospital of Wuhan University
- Study coordinator: Honggang Yu, PhD
- Email: yuhonggang1968@163.com
- Phone: 13871281899
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving care and surveillance of fevers in the DRC
This project tracked people with recent fevers at two hospitals in the DRC to see what causes their fevers, how they are treated, and whether biomarkers like CRP relate to outcomes and antibiotic use.
-
Predicting airway problems in children with tracheostomies using caregiver and pediatrician reports.
We will see if symptoms reported by caregivers or pediatricians can predict airway complications found during routine surveillance endoscopy in children with tracheostomies.
-
Ivarmacitinib with Camrelizumab and Fruquintinib in advanced colorectal cancer after prior therapies
This trial tests whether combining ivarmacitinib with camrelizumab and fruquintinib can help patients with metastatic colorectal cancer who have progressed after multiple treatments.
-
Low-intensity ultrasound to calm the nerves and improve sleep after heart surgery
This trial tests whether gentle, focused ultrasound on the left stellate ganglion can improve autonomic function and sleep after heart-related surgery in adults with cardiovascular disease, compared with a sham treatment.
-
Ultrasound treatment to calm neck nerves after a heart attack to stop dangerous rhythms
This trial tests whether low-intensity focused ultrasound to the left Stellate ganglion can reduce ventricular arrhythmias after a STEMI treated with PCI.
-
Giving heparin before arrival for people with STEMI who will have primary PCI.
This trial will test whether giving an IV loading dose of unfractionated heparin before hospital arrival helps adults with STEMI who are going for primary PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.